4761. Effective post-pandemic governance must focus on shared challenges.
作者: Anne Williamson.;Rebecca Forman.;Natasha Azzopardi-Muscat.;Robert Battista.;Francesca Colombo.;Amanda Glassman.;Josep Figueras Marimont.;Beata Javorcik.;Jim O'Neill.;Alistair McGuire.;Martin McKee.;Mario Monti.;Gus O'Donnell.;Clare Wenham.;Robert Yates.;Sally Davies.;Elias Mossialos.
来源: Lancet. 2022年399卷10340期1999-2001页 4762. Acute onset of fever, eosinophilia, rash, acute kidney injury, and a positive Monospot test in a patient on lamotrigine: DRESS syndrome.
作者: Mahmoud Abdelnabi.;Marawan Elmassry.;Jasmine Sekhon.;Juthipong Benjanuwattra.
来源: Lancet. 2022年399卷10338期1902页 4763. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
作者: Alan Pollack.;Theodore G Karrison.;Alexander G Balogh.;Leonard G Gomella.;Daniel A Low.;Deborah W Bruner.;Jeffrey S Wefel.;Andre-Guy Martin.;Jeff M Michalski.;Steve J Angyalfi.;Himanshu Lukka.;Sergio L Faria.;George B Rodrigues.;Marie-Claude Beauchemin.;R Jeffrey Lee.;Samantha A Seaward.;Aaron M Allen.;Drew C Monitto.;Wendy Seiferheld.;Oliver Sartor.;Felix Feng.;Howard M Sandler.
来源: Lancet. 2022年399卷10338期1886-1901页
In men with a detectable prostate-specific antigen (PSA) level after prostatectomy for prostate cancer, salvage prostate bed radiotherapy (PBRT) results in about 70% of patients being free of progression at 5 years. A three-group randomised trial was designed to determine whether incremental gains in patient outcomes can be achieved by adding either 4-6 months of short-term androgen deprivation therapy (ADT) to PBRT, or both short-term ADT and pelvic lymph node radiotherapy (PLNRT) to PBRT.
|